|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ruiterkamp J, Voogd AC, Tjan-Heijnen VC,
Bosscha K, van der Linden YM, Rutgers EJ, Boven E, van der Sangen
MJ and Ernst MF; Dutch Breast Cancer Trialists' Group (BOOG), :
SUBMIT: Systemic therapy with or without upfront surgery of the
primary tumor in breast cancer patients with distant metastases at
initial presentation. BMC Surg. 12:52012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kölbl AC, Andergassen U and Jeschke U: The
role of glycosylation in breast cancer metastasis and cancer
control. Front Oncol. 5:2192015. View Article : Google Scholar
|
|
4
|
Vajaria BN, Patel KR, Begum R and Patel
PS: Sialylation: An avenue to target cancer cells. Pathol Oncol
Res. 22:443–447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Petretti T, Kemmner W, Schulze B and
Schlag PM: Altered mRNA expression of glycosyltransferases in human
colorectal carcinomas and liver metastases. Gut. 46:359–366. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma XL, Dong WJ, Su Z, Zhao LF, Miao Y, Li
NN, Zhou HM and Li J: Functional roles of sialylation in breast
cancer progression through miR-26a/26b targeting ST8SIA4. Cell
Death Dis. 7:e25612016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bach DH and Lee SK: Long noncoding RNAs in
cancer cells. Cancer Lett. 419:152–166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tu ZQ, Li RJ, Mei JZ and Li XH:
Down-regulation of long non-coding RNA GAS5 is associated with the
prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol.
7:4303–4309. 2014.PubMed/NCBI
|
|
10
|
Hombach S and Kretz M: Non-coding RNAs:
Classification, biology and functioning. Adv Exp Med Biol.
937:3–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li ZX, Zhu QZ, Zhang HB, Hu Y, Wang G and
Zhu YS: MALAT1: A potential biomarker in cancer. Cancer Manag Res.
10:6757–6768. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Yang F, Chen SJ, Che JP and Zheng
JH: Upregulation of long non-coding RNA MALAT1 correlates with
tumor progression and poor prognosis in clear cell renal cell
carcinoma. Tumor Biol. 36:2947–2955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun JY, Zhao ZW, Li WM, Yang G, Jing PY,
Li P, Dang HZ, Chen Z, Zhou YA and Li XF: Knockdown of MALAT1
expression inhibits HUVEC proliferation by upregulation of miR-320a
and downregulation of expression. Oncotarget. 8:61449–61509.
2017.
|
|
14
|
Wu Y, Sarkissyan M, Ogah O, Kim J and
Vadgama JV: Expression of MALAT1 promotes trastuzumab resistance in
HER2 overexpressing breast cancers. Cancers (Basel). 12:19182020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Browne G, Dragon JA, Hong D, Messier TL,
Gordon JA, Farina NH, Boyd JR, VanOudenhove JJ, Perez AW, Zaidi SK,
et al: MicroRNA-378-mediated suppression of Runx1 alleviates the
aggressive phenotype of triple-negative MDA-MB-231 human breast
cancer cells. Tumour Biol. 37:8825–8839. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Luo DL, Tian WG, Li ZR and Zhang
XH: Demethylation of miR-495 inhibits cell proliferation, migration
and promotes apoptosis by targeting STAT-3 in breast cancer. Oncol
Rep. 37:3581–3589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li C, Huo B, Wang Y and Cheng C:
Downregulation of microRNA-92b-3p suppresses proliferation,
migration, and invasion of gastric cancer SGC-7901 cells by
targeting Homeobox D10. J Cell Biochem. 120:17405–17412. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chan JJ and Tay Y: Noncoding RNA: RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Zhu Z, Huang S, Zhao Q, Huang C,
Tang Y, Sun C, Zhang Z, Wang L, Chen H, et al: LncRNA XIST
regulates proliferation and migration of hepatocellular carcinoma
cells by acting as miR-497-5p molecular sponge and targeting PDCD4.
Cancer Cell Int. 19:1982019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao Z, Sun W, Guo Z, Zhang J, Yu H and
Liu B: Mechanisms of lncRNA/microRNA interactions in angiogenesis.
Life Sci. 254:1169002020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X, Teer JK, Tousignant RN, Levin AM,
Boulware D, Chitale DA, Shaw BM, Chen Z, Zhang Y, Blakeley JO, et
al: Breast cancer risk and germline genomic profiling of women with
neurofibromatosis type 1 who developed breast cancer. Genes
Chromosomes Cancer. 57:19–27. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amelio I, Bernassola F and Candi E:
Emerging roles of long non-coding RNAs in breast cancer biology and
management. Semin Cancer Biol. 72:36–45. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dimartino D, Colantoni A, Ballarino M,
Martone J, Mariani D, Danner J, Bruckmann A, Meister G, Morlando M
and Bozzoni I: The long non-coding RNA lnc-31 interacts with Rock1
mRNA and mediates its YB-1-dependent translation. Cell Rep.
23:733–740. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu B, Liu Q, Pan S, Huang Y, Qi Y, Li S,
Xiao Y and Jia L: The HOTAIR/miR-214/ST6GAL1 crosstalk modulates
colorectal cancer procession through mediating sialylated c-Met via
JAK2/STAT3 cascade. J Exp Clin Cancer Res. 38:4552019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guan YX, Zhang MZ, Chen XZ, Zhang Q, Liu
SZ and Zhang YL: Lnc RNA SNHG20 participated in proliferation,
invasion, and migration of breast cancer cells via miR-495. J Cell
Biochem. 119:7971–7981. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao Z, Zhou H, Wang Y, Chen J and Ou Y:
Regulatory effects of lncRNA ATB targeting miR-200c on
proliferation and apoptosis of colorectal cancer cells. J Cell
Biochem. 121:332–343. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiao Y, Pan J, Geng Q and Wang G: LncRNA
MALAT1 increases the stemness of gastric cancer cells via enhancing
SOX2 mRNA stability. FEBS Open Bio. 9:1212–1222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zuo Y, Li Y, Zhou Z, Ma M and Fu K: Long
non-coding RNA MALAT1 promotes proliferation and invasion via
targeting miR-129-5p in triple-negative breast cancer. Biomed
Pharmacother. 95:922–928. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun Z and Liu J and Liu J: The expression
of lncRNA-MALAT1 in breast cancer patients and its influences on
prognosis. Cell Mol Biol (Noisy-le-grand). 66:72–78. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arun G and Spector DL: MALAT1 long
non-coding RNA and breast cancer. RNA Biol. 16:860–863. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Z, Xu C, Ding B, Gao M, Wei X and Ji N:
Long non-coding RNA MALAT1 promotes proliferation and suppresses
apoptosis of glioma cells through derepressing Rap1B by sponging
miR-101. J Neurooncol. 134:19–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pan Y, Tong S, Cui R, Fan J, Liu C, Lin Y,
Tang J, Xie H, Lin P, Zheng T, et al: Long non-coding MALAT1
functions as a competing endogenous RNA to regulate vimentin
expression by sponging miR-30a-5p in hepatocellular carcinoma. Cell
Physiol Biochem. 50:108–120. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Sun Z, Liu B, Shan Y, Zhao L and Jia
L: Tumor-suppressive miR-26a and miR-26b inhibit cell
aggressiveness by regulating FUT4 in colorectal cancer. Cell Death
Dis. 8:e28922017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu Y, Lu Y, Zhang Q, Liu JJ, Li TJ, Yang
JR, Zeng C and Zhuang SM: MicroRNA-26a/b and their host genes
cooperate to inhibit the G1/S transition by activating the pRb
protein. Nucleic Acids Res. 40:4615–4625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kato M, Goto Y, Matsushita R, Kurozumi A,
Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M,
Ichikawa T and Seki N: MicroRNA-26a/b directly regulate La-related
protein 1 and inhibit cancer cell invasion in prostate cancer. Int
J Oncol. 47:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li F and Ding J: Sialylation is involved
in cell fate decision during development, reprogramming and cancer
progression. Protein Cell. 10:550–565. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Garnham R, Scott E, Livermore KE and
Munkley J: ST6GAL1: A key player in cancer. Oncol Lett. 18:983–989.
2019.PubMed/NCBI
|
